HIV Infections Clinical Trials

A listing of HIV Infections medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 174 clinical trials
Adolescent Sexually Transmitted Infection Screening in the Emergency Department (STI)

Sexually transmitted infections (STIs) are highly prevalent among adolescents. Despite established principles for STI control, clinical practices related to screening and diagnosis, treatment, and prevention of STIs among adolescents are suboptimal. There is an urgent need to expand our screening programs to nontraditional healthcare settings such as emergency departments (ED) …

chlamydial infection
infection screening
targeted screening
gonorrhea
Accepts healthy volunteers
  • 88 views
  • 10 Aug, 2022
  • 1 location
Inflammation, NK Cells, Antisense Protein and Exosomes, and Correlation With Immune Response During HIV Infection (INKASE)

through its interaction with its cellular partner Bat-3. Once externalized in soluble or exosomal form, Bat-3 has the ability to regulate NK cell activity. During HIV infection, NK functions are

  • 0 views
  • 20 Sep, 2022
Treating Insomnia to Reduce Inflammation in HIV

This randomized trial will determine the effects of internet cognitive behavioral therapy on measures of systemic inflammation in HIV-positive people receiving antiretroviral therapy.

antiretroviral therapy
hiv test
behavior therapy
HIV Vaccine
AIDS
  • 0 views
  • 19 Sep, 2022
  • 1 location
Effects of Sacubitril/Valsartan on Subclinical Heart Failure in HIV (The ENCHANTMENT HIV Study)

Persons with HIV, even those well-treated, are at increased risk for heart disease when compared to the general population. Two hormones called aldosterone and brain natriuretic peptide (BNP

heart failure
hiv viral load
antiretroviral agents
valsartan
antiretroviral therapy
  • 0 views
  • 09 Aug, 2022
A Phase I Study of Ipilimumab and Nivolumab in Advanced HIV-Associated Solid Tumors With Expansion Cohorts in HIV-Associated Solid Tumors and a Cohort of HIV-Associated Classical Hodgkin Lymphoma

This phase I trial studies the side effects and best dose of nivolumab when given with ipilimumab in treating patients with human immunodeficiency virus (HIV) associated classical Hodgkin

g-csf
tumor cells
cancer chemotherapy
hiv-1 infection
measurable disease
  • 226 views
  • 20 Sep, 2022
  • 23 locations
Neuroinflammation and Modulating Factors in Depression and HIV

Determine if depression, which persists after depression treatment at 26 weeks, is associated with increased innate inflammation in a prospective cohort of HIV-infected Ugandans receiving SSRIs

depressive symptoms
psychotherapy
depressed mood
antiretroviral therapy
selective serotonin reuptake inhibitors
  • 0 views
  • 12 Aug, 2022
  • 1 location
Phase I Study of MK-3475 (Pembrolizumab) in Patients With Human Immunodeficiency Virus (HIV) and Relapsed/Refractory or Disseminated Malignant Neoplasm

This phase I trial studies the side effects of pembrolizumab in treating patients with human immunodeficiency virus (HIV) and malignant neoplasms that have come back (relapsed), do not respond

tumor cells
stem cell transplant
x-rays
measurable disease
b-cell lymphoma
  • 142 views
  • 21 Sep, 2022
  • 6 locations
Randomized, Controlled Trial to Evaluate the Anti-inflammatory Efficacy of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive ART and Its Effect on Chronic Inflammation, HIV Persistence, and Other Clinical Outcomes (ELICIT)

This is an open-label, controlled study, conducted at US sites to evaluate the anti-inflammatory effectiveness of the study drug letermovir in adults with HIV and asymptomatic cytomegalovirus

immune globulin
immunodeficiency
atazanavir
hiv test
hysterectomy
  • 0 views
  • 14 Sep, 2022
  • 1 location
A Phase 1, Single-blind, Dose-escalation Study to Assess the Safety and Tolerability of Brentuximab Vedotin (ADCETRIS®) in Subjects With Human Immunodeficiency Virus (HIV)

This study will test brentuximab vedotin to see if it is safe for people with human immunodeficiency virus (HIV) who have low CD4+ and have received antiretroviral therapy (ART) treatment. It

hiv viral load
hepatitis
immunodeficiency
antiretroviral therapy
  • 0 views
  • 21 Sep, 2022
  • 1 location
CPT-L to Improve Outcomes for Individuals With HIV and PTSD

This study plans to adapt and examine the acceptability and feasibility of an evidence-based PTSD treatment that has reduced other HIV transmission behavior (e.g., sexual risk), Cognitive

cognitive training
  • 0 views
  • 08 Aug, 2022
  • 1 location